CLINICAL_TRIALS
trial_result
· 2015-12-23
Clinical Trial Update: Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects [Phase 2]
Summary
Phase 2 trial evaluating an anti-PCSK9 antibody in statin-intolerant subjects with hyperlipidemia; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Hyperlipidemia | Phase 2 | Status: COMPLETED | Results posted: 2015-12-23